1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New York >
  6. Sana Biotechnology Acquires Oscine Therapeutics

M&A Deal Summary

Sana Biotechnology Acquires Oscine Therapeutics

On October 30, 2020, Sana Biotechnology acquired life science company Oscine Therapeutics

Acquisition Highlights
  • This is Sana Biotechnology’s 1st transaction in the Life Science sector.
  • This is Sana Biotechnology’s 1st transaction in the United States.
  • This is Sana Biotechnology’s 1st transaction in New York.

M&A Deal Summary
Date 2020-10-30
Target Oscine Therapeutics
Sector Life Science
Buyer(s) Sana Biotechnology
Deal Type Add-on Acquisition

Target

Oscine Therapeutics

Rochester , New York, United States
Oscine Therapeutics is a company developing potentially curative or disease-modifying cell therapies for diseases of the brain and central nervous system (CNS). Oscine Therapeutics is based in Rochester, New York.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sana Biotechnology

Seattle, Washington, United States
Category Company
Founded 2018
Sector Life Science
Employees194
DESCRIPTION

Sana Biotechnology is focused on creating and delivering engineered cells as medicines for patients. Sana Biotechnology offers to repair and controlling genes, replacing missing or damaged cells, and making therapies broadly available to patients. Sana Biotechnology was founded in 2018 and is based in Seattle, Washington.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New York M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2020 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal